ClinicalTrials.Veeva

Menu

Thermal Preconditioning in Mastectomy Patients With Immediate Breast Reduction

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Begins enrollment this month

Conditions

Breast Reconstruction After Mastectomy

Treatments

Other: 1 Cycle Thermal Preconditioning
Other: 3 Cycles Thermal Preconditioning
Other: No Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT07516483
IRB00146716

Details and patient eligibility

About

The purpose of this research study is to understand patient experiences and the feasibility of using a breast heat preconditioning device (Plexaa BLOOM43), designed to improve postoperative outcomes when used prior to mastectomy and breast reconstruction.

Full description

This study will be a prospective, single-center, two-arm randomized trial comparing two preconditioning interventions, with a separate retrospective cohort serving as the standard of care control group without preconditioning. For the prospective component, eligible patients undergoing mastectomy with preoperative plan of undergoing immediate autologous or device-based breast reconstruction at the Atrium Health Wake Forest Baptist Medical Center will be randomized in a 1:1 ratio into a 3-cycle or 1-cycle treatment group. There will also be a retrospective chart review to create a control group.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (≥ 18 years of age) undergoing prophylactic or therapeutic mastectomy with planned immediate breast reconstruction at Atrium Health Wake Forest Baptist Medical Center.

Exclusion criteria

  • Patients with no plan for any breast reconstruction.
  • Patients with inflammatory breast cancer.
  • History of any radiation to the breast or chest wall.
  • Patients with pre-existing local dermatological conditions.
  • Patients belonging to vulnerable populations (e.g., children, pregnant individuals, incarcerated persons).
  • Patients unable to provide informed consent or comply with study procedures.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 3 patient groups

3 Preconditioning Cycles
Experimental group
Description:
three cycles of alternating between 30 minutes heating and 30 minutes spontaneous cooling to the breast 12 hours before operation.
Treatment:
Other: 3 Cycles Thermal Preconditioning
1 Preconditioning Cycle
Experimental group
Description:
one cycle of alternating between 30 minutes heating and 30 minutes cooling in the preoperative area 1 hour before operation.
Treatment:
Other: 1 Cycle Thermal Preconditioning
Retrospective Group
Active Comparator group
Description:
retrospective chart review of patients meeting the same eligibility criteria who did not receive prospective interventions
Treatment:
Other: No Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Caleb Suggs

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems